Product Information
- 6-Benzofuransulfonamide, 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]-
PTP1B Inhibitor is a drug that is used to treat type 2 diabetes. It inhibits the activation of PTP1B, a protein that regulates the uptake of glucose from the blood. This inhibition decreases insulin-stimulated glucose uptake and increases sodium-dependent glucose uptake in peripheral tissues. PTP1B Inhibitor is also known as an antidiabetic agent due to its ability to regulate insulin secretion and blood sugar levels. The hydrogen bonds between this drug and human protein are very stable, which makes it more difficult for enzymes to break down the complex. PTP1B Inhibitor has been shown to have an effect on fatty acid metabolism and signal pathways, leading to potential metabolic disorders such as obesity or type 2 diabetes.
Chemical properties
Technical inquiry about: 3D-QFB31772 PTP1B Inhibitor
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
